LNPs and beyond: nanoscale delivery systems in advanced therapy applications

Cell & Gene Therapy Insights 2023; 9(5), 467–472

DOI: 10.18609/cgti.2023.069

Published: 18 May 2023
Shashank Pinnapireddy

David McCall, Senior Editor, BioInsights, speaks to Shashank Pinnapireddy, Head of Nanoparticle Research, CSL Behring Innovation, about his work on nanoscale delivery systems and in particular, lipid nanoparticles (LNPs), which has become a major technology field of interest in the advanced therapies realm following their ‘proof of concept’ application in the prophylactic COVID-19 vaccine setting.